Today, I’m joined by Dr. Daisy Robinton, co-founder & CEO of Oviva Therapeutics.

Daisy is a Harvard-trained molecular biologist on a mission to extend female healthspan. Targeting ovarian function as a lever for longevity, Oviva hopes to make menopause optional.

In this episode, we discuss how Oviva Therapeutics plans to deliver additional years of vibrant living to women. Plus, we talk about the intersection of biology and longevity.

We also cover:
• The future of women’s health
• How lifestyle interventions impact aging
• Oviva’s process for developing novel therapeutics

Subscribe to the podcast → insider.fitt.co/podcast
Subscribe to our newsletter → insider.fitt.co/subscribe
Follow us on LinkedIn → linkedin.com/company/fittinsider

Oviva Therapeutics Website: https://www.ovivatx.com/
Daisy’s LinkedIn: https://www.linkedin.com/in/daisy-robinton-phd-97785b35/
Daisy’s IG: https://www.instagram.com/daisy_robinton/?hl=en
Daisy’s Email: Daisy@ovivatx.com
Daisy Speaking at SXSW: https://www.shemedia.com/sxsw-2024/speakers
Daisy Speaking at Live Long Summit: https://www.livelongsummit.com/

-

The Fitt Insider Podcast is brought to you by EGYM. Visit EGYM.com to learn more about its smart workout solutions for fitness and health facilities.

Fitt Talent: https://talent.fitt.co/
Consulting: https://consulting.fitt.co/
Investments: https://capital.fitt.co/

Chapters:
(00:00) Introduction
(01:31) Oviva Therapeutic background
(03:35) Understanding ovarian aging
(07:09) Oviva’s scientific research
(10:08) Challenges and opportunities in women's health
(11:34) Operations of a biotech company
(16:00) Oviva’s long-term goals
(19:35) The future of women's health and longevity
(20:46) Preserving ovarian function
(21:50) Therapeutic interventions and lifestyle changes for women's health
(23:29) Timeline for the therapeutics to be released
(26:01) Consumer education and regulatory changes
(31:52) Efficacy and skepticism
(35:24) Conclusion

226. Dr. Daisy Robinton, Co-founder & CEO of Oviva Therapeutics

Fitt Insider